デフォルト表紙
市場調査レポート
商品コード
1647935

喘息モニタリングデバイスの世界市場 - 産業規模、シェア、動向、機会、予測:デバイス別、エンドユーザー別、地域別、競合別(2020年~2030年)

Asthma Monitoring Device Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device, By End-User, By Region and Competition, 2020-2030F


出版日
ページ情報
英文 180 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

喘息モニタリングデバイスの世界市場 - 産業規模、シェア、動向、機会、予測:デバイス別、エンドユーザー別、地域別、競合別(2020年~2030年)
出版日: 2025年01月31日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の喘息モニタリングデバイスの市場規模は、2024年に2億8,513万米ドルで、予測期間中のCAGRは6.26%で2030年には4億586万米ドルに達すると予測されています。

世界の喘息モニタリングデバイス市場は、喘息の有病率の増加、喘息管理に対する意識の高まり、医療技術の絶え間ない進歩により、一貫した成長を遂げています。喘息は、気道の炎症と狭窄を特徴とする慢性呼吸器疾患で、世界中で数百万人が罹患しています。モニタリングデバイスは、肺機能の評価、症状の追跡、再燃を抑え生活の質を高めるための治療管理において重要な役割を果たしています。世界保健機関(WHO)によると、5億人近くが喘息と慢性閉塞性肺疾患(COPD)を抱えて生活しており、この2つの疾患は年間400万人近くの死亡原因となっており、そのうち100万人以上が70歳未満で早期死亡しています。驚くべきことに、早期死亡の90%は中低所得国(LMICs)で発生しています。政府や医療機関は、喘息管理の改善を積極的に推進しており、モニタリングデバイスの普及が進んでいます。早期発見と予防に関する一般市民への啓蒙活動により、モニタリングデバイスの継続的な使用がさらに奨励されています。しかし、先進的な喘息モニタリングデバイスの高額な費用は、一部の患者、特に低所得地域にとっては法外であり、その普及を制限しています。さらに、都市部ではこうした機器の使用が増加していますが、地方では依然として認知度やアクセシビリティに課題があり、市場浸透の妨げとなっています。

市場概要
予測期間 2026年~2030年
市場規模:2024年 2億8,513万米ドル
市場規模:2030年 4億586万米ドル
CAGR:2025年~2030年 6.26%
急成長セグメント スマート吸入器
最大市場 北米

2024年10月、FDAと疾病対策予防センター(CDC)は、2024年全国青少年たばこ調査(NYTS)から得られた青少年のたばこ使用に関する調査結果をMorbidity and Mortality Weekly Reportで発表しました。このデータから、225万人の中高生が過去30日間のうち1日以上、少なくとも1本のタバコ製品を使用したと報告したことが明らかになりました。新興諸国における医療インフラの拡充と喘息管理に対する意識の高まりは、市場に大きな成長機会をもたらしています。新興市場における都市化の進展は、喘息モニタリングソリューションの需要を促進する可能性が高いです。さらに、モニタリングデバイスを遠隔医療プラットフォームと統合することで、医療提供者は特に遠隔地の患者を遠隔で追跡し、治療を調整できるようになります。この動向は今後数年で拡大すると予想されます。高コストや地域的なアクセス格差といった課題は残りますが、遠隔医療の統合とともに新興市場における機会は、継続的な市場成長の道を提供します。技術革新と患者エンゲージメントの向上に注力することで、喘息モニタリングデバイス市場は急速に進化し、世界中の喘息患者により効果的なソリューションを提供する態勢が整っています。

主な市場促進要因

喘息の有病率の上昇

遠隔患者モニタリングの重視の高まり

意識と教育の向上

主な市場課題

限られた償還政策

相互運用性の問題

主な市場動向

遠隔医療と遠隔モニタリング

小児喘息モニタリングへの注目

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の喘息モニタリングデバイス市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • デバイス別(スパイロメーター、スマート吸入器、ピークフローメーター)
    • エンドユーザー別(病院・診療所、在宅ケア、診断研究所)
    • 地域別(北米、欧州、アジア太平洋、南米、中東・アフリカ)
    • 企業別(2024年)
  • 市場マップ
  • デバイス別
  • エンドユーザー別
  • 地域別

第6章 北米の喘息モニタリングデバイス市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • デバイス別
    • エンドユーザー別
    • 国別
  • 北米:国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の喘息モニタリングデバイス市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • デバイス別
    • エンドユーザー別
    • 国別
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋の喘息モニタリングデバイス市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • デバイス別
    • エンドユーザー別
    • 国別
  • アジア太平洋:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の喘息モニタリングデバイス市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • デバイス別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの喘息モニタリングデバイス市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • デバイス別
    • エンドユーザー別
    • 国別
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 世界の喘息モニタリングデバイス市場:SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • COSMED srl.
  • Teleflex Incorporated.
  • SCHILLER.
  • Hill-Rom, Inc.
  • Koninklijke Philips N.V.
  • ICU Medical, Inc.
  • SDI Diagnostics
  • AstraZeneca plc.
  • Merck & Co., Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 20032

Global Asthma Monitoring Device Market was valued at USD 285.13 Million in 2024 and is expected to reach USD 405.86 Million by 2030 with a CAGR of 6.26% during the forecast period. The global asthma monitoring device market is experiencing consistent growth driven by the increasing prevalence of asthma, heightened awareness of asthma management, and continuous advancements in medical technologies. Asthma, a chronic respiratory condition marked by airway inflammation and narrowing, affects millions of individuals globally. Monitoring devices play a vital role in evaluating lung function, tracking symptoms, and managing treatment to reduce flare-ups and enhance quality of life. According to the World Health Organization (WHO), nearly half a billion people live with asthma and chronic obstructive pulmonary disease (COPD), and these two conditions are responsible for almost 4 million deaths annually, with over 1 million of those deaths occurring prematurely in individuals under 70 years old. Alarmingly, 90% of premature deaths occur in low- and middle-income countries (LMICs). Governments and healthcare organizations are actively promoting better asthma management, leading to greater adoption of monitoring devices. Public education on early detection and prevention further encourages consistent use of these devices. However, the high cost of advanced asthma monitoring equipment may be prohibitive for some patients, particularly in lower-income regions, limiting their widespread adoption. Additionally, while urban populations increasingly use these devices, rural areas continue to face challenges with awareness and accessibility, impeding market penetration.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 285.13 Million
Market Size 2030USD 405.86 Million
CAGR 2025-20306.26%
Fastest Growing SegmentSmart Inhalers
Largest MarketNorth America

In October 2024, the FDA and the Centers for Disease Control and Prevention (CDC) published findings from the 2024 National Youth Tobacco Survey (NYTS) regarding youth tobacco use in the Morbidity and Mortality Weekly Report. The data revealed that 2.25 million middle and high school students reported using at least one tobacco product on one or more days in the past 30 days. The expansion of healthcare infrastructure and growing awareness about asthma management in developing countries offer significant growth opportunities for the market. The rising urbanization in emerging markets is likely to drive the demand for asthma monitoring solutions. Moreover, the integration of monitoring devices with telemedicine platforms enables healthcare providers to remotely track and adjust treatments for patients, especially in remote areas. This trend is expected to grow in the coming years. Although challenges such as high costs and regional access disparities remain, opportunities in emerging markets, along with the integration of telemedicine, offer avenues for continued market growth. With a focus on innovation and improved patient engagement, the asthma monitoring device market is poised to evolve rapidly, providing more effective solutions for asthma patients around the world.

Key Market Drivers

Rising Prevalence of Asthma

The growing global prevalence of asthma is expected to significantly drive the expansion of the Global Asthma Monitoring Device Market. According to the GINA 2024 Report, asthma is one of the most common chronic non-communicable diseases, affecting over 300 million people and causing around 1,000 deaths daily worldwide, many of which are preventable. As asthma incidence continues to rise, the demand for effective and efficient monitoring solutions to manage and control the condition is also increasing. This heightened demand is expected to spur innovation and attract investment in asthma monitoring devices, further fueling market growth. Asthma monitoring devices play a crucial role in enabling individuals to track and manage their respiratory health, providing real-time data and insights to both patients and healthcare professionals. As patient awareness of the importance of proactive asthma management grows, the adoption of these monitoring devices is expected to increase, supporting market growth. Additionally, advancements in technology such as the integration of smart features and wireless connectivity are improving user experience and enabling remote monitoring, which will further drive the market's expansion. In Ireland, for example, the Asthma Society of Ireland reports that 890,000 people will experience asthma at some point in their lives, with 380,000 individuals currently affected. One in 13 people and one in 10 children in Ireland are living with asthma. The rising asthma prevalence, combined with the growing emphasis on personalized healthcare and the adoption of innovative technologies, positions the asthma monitoring device market for substantial growth in the near future.

Growing Emphasis on Remote Patient Monitoring

The burgeoning emphasis on Remote Patient Monitoring (RPM) is poised to be a key catalyst in propelling the growth of the Global Asthma Monitoring Device Market. With a paradigm shift towards decentralized healthcare, the demand for Asthma Monitoring Devices is escalating due to their integral role in facilitating remote tracking of patients' respiratory health. As healthcare systems increasingly prioritize preventive care and patient-centric approaches, these monitoring devices offer a crucial solution for continuous, real-time assessment without the necessity of frequent in-person visits. The integration of Asthma Monitoring Devices with wireless connectivity and smart technologies enables seamless data transmission to healthcare professionals, fostering timely intervention and personalized care plans. This not only empowers patients to actively manage their condition but also allows healthcare providers to make informed decisions remotely, improving overall patient outcomes. The growing adoption of telehealth practices and the need for efficient chronic disease management, especially in the context of asthma, positions the Asthma Monitoring Device Market at the forefront of technological innovation and remote healthcare delivery. This trend is anticipated to drive sustained market growth as the healthcare landscape continues to evolve towards patient-centric, technology-enabled solutions.

Increasing Awareness and Education

The growth of the Global Asthma Monitoring Device Market is set to be significantly driven by a rise in awareness and education around respiratory health. As awareness campaigns and educational efforts gain momentum, more individuals are recognizing the importance of effectively monitoring and managing asthma. For example, Philips' awareness campaign educates consumers on asthma and helps people better manage their symptoms. This growing awareness is leading to a heightened demand for asthma monitoring devices, as people adopt a more proactive and informed approach to respiratory care.

Education on the benefits of continuous asthma monitoring, as well as the role these devices play in early detection and management, is key to encouraging their widespread adoption. Patients are increasingly seeking these devices as part of their regular healthcare routines. Additionally, CIPLA, India's third-largest pharmaceutical company, has launched a campaign (#InhalersHainSahi) to raise awareness about asthma and emphasize the vital role inhalers play in managing the condition. As asthma continues to be a global health challenge, improving awareness and preparedness is critical to effectively combating the disease.

Investing in asthma prevention efforts, including health education and innovative strategies, is essential to raising community awareness and promoting preventative practices. These educational initiatives are also beneficial for healthcare professionals, who are now better equipped to recommend and incorporate asthma monitoring devices into personalized care plans, further driving market growth. The convergence of technology and healthcare education is particularly impactful, as informed consumers are more inclined to embrace innovative solutions. As a result, the Global Asthma Monitoring Device Market is poised to benefit significantly from this increasing awareness, expanding its market base as more individuals take a proactive approach to managing their respiratory health.

Key Market Challenges

Limited Reimbursement Policies

Limited reimbursement policies pose a significant obstacle to the growth of the Global Asthma Monitoring Device Market. The financial landscape of healthcare is a crucial determinant of consumer adoption and healthcare provider recommendation of monitoring devices. When reimbursement policies are restrictive or inadequately cover the costs associated with Asthma Monitoring Devices, both patients and healthcare institutions may be deterred from investing in these technologies. Healthcare providers often rely on reimbursement support to justify the integration of new technologies into patient care. Limited coverage for asthma monitoring devices may result in decreased willingness to prescribe or recommend these devices, hindering their market penetration. This, in turn, affects patient access and adoption rates, especially among those who depend on insurance coverage for medical expenses. For patients, out-of-pocket costs can be a significant barrier to acquiring these devices, leading to suboptimal management of asthma. The market's growth is inherently linked to the alignment of reimbursement policies with the value proposition of asthma monitoring devices, and addressing these limitations is pivotal for fostering widespread adoption and ensuring the sustained growth of the Asthma Monitoring Device Market on a global scale.

Interoperability Issues

Interoperability issues present a formidable barrier to the growth of the Global Asthma Monitoring Device Market. The seamless exchange of data between various healthcare systems, electronic health records (EHRs), and monitoring devices is crucial for the effective management of chronic conditions like asthma. However, disparate standards and a lack of standardized protocols for data communication hinder the smooth integration of asthma monitoring devices into existing healthcare ecosystems. When interoperability is compromised, healthcare providers face challenges in accessing and utilizing the data generated by these devices, leading to fragmented patient care. The inability of asthma monitoring devices to seamlessly communicate with other health information systems not only impedes efficient care coordination but also diminishes the overall value proposition of these devices. Moreover, interoperability issues may contribute to increased implementation costs for healthcare institutions, as they may need to invest in additional infrastructure or customized solutions to overcome compatibility challenges. This, in turn, can slow down the adoption rate of asthma monitoring devices on a broader scale. To foster the growth of the Asthma Monitoring Device Market, addressing interoperability challenges is imperative. Standardizing communication protocols and promoting interoperable solutions will enhance the utility of these devices, driving their integration into comprehensive healthcare strategies and ultimately benefiting both healthcare providers and patients.

Key Market Trends

Telehealth and Remote Monitoring

The Global Asthma Monitoring Device Market is set to experience accelerated growth due to the rising prominence of telehealth and remote monitoring solutions. According to data from the US Centers for Disease Control (CDC), published in the American Journal of Managed Care, asthma is estimated to cost USD 80 billion annually. Telehealth, combined with asthma monitoring devices, presents a transformative approach to managing respiratory health. The convenience and accessibility of remote monitoring empower patients to actively engage in their care, facilitating early interventions and tailored treatment plans.

By integrating asthma monitoring devices with telehealth platforms, real-time data can be transmitted to healthcare providers, enabling proactive decision-making without the need for in-person visits. This not only boosts patient engagement but also streamlines healthcare delivery, particularly in remote or underserved areas. The global shift toward telehealth, fueled by technological advancements and the growing demand for virtual healthcare options, creates a favorable environment for the widespread adoption of asthma monitoring devices.

For example, in February 2024, Singapore-based respiratory monitoring device company Aevice Health partnered with London-based Jiva.ai to develop a remote patient monitoring platform that enables individuals with asthma to track their condition and predict asthma attacks. This collaboration, partly funded by the UK government's Innovate UK business grant scheme and Singapore's Enterprise Singapore, leverages the FDA-approved AeviceMD, a wearable smart stethoscope that continuously monitors asthma biomarkers. This system allows patients to monitor their condition from home while providing healthcare providers with valuable insights to optimize care. As telehealth becomes a core element of modern healthcare systems, the integration of telehealth with asthma monitoring devices is poised to drive market growth by delivering efficient, patient-centered solutions that align with the evolving healthcare landscape.

Focus on Pediatric Asthma Monitoring

The Global Asthma Monitoring Device Market is poised for substantial growth with an increasing focus on pediatric asthma monitoring. Recognizing the unique needs and challenges of managing asthma in children, there is a growing demand for specialized monitoring devices tailored to the pediatric population. This emphasis on pediatric asthma care is driven by a heightened awareness of the prevalence of childhood asthma and the importance of early intervention. Pediatric asthma monitoring devices offer features specifically designed to address the developmental and behavioral aspects of children, making it easier for parents and healthcare providers to manage the condition effectively. The integration of child-friendly designs, user-friendly interfaces, and interactive features enhances compliance and engagement, ensuring accurate and consistent monitoring. Moreover, the rising incidence of pediatric asthma, coupled with a proactive approach towards preventive healthcare, positions the market for pediatric asthma monitoring devices as a critical component in the overall asthma management landscape. As healthcare providers and parents prioritize the well-being of children with asthma, the market is expected to witness sustained growth by catering to the specific needs of this demographic, ultimately contributing to improved health outcomes for pediatric asthma patients globally.

Segmental Insights

Device Insights

Based on Device, the Smart Inhalers emerged as the fastest growing segment in the global market for Asthma Monitoring Device during the forecast period. The Global Asthma Monitoring Device Market is set to experience robust growth driven by the integration of Smart Inhalers. These innovative devices represent a paradigm shift in asthma management, combining traditional inhalers with digital technology to provide real-time data and insights. Smart Inhalers not only ensure accurate medication delivery but also offer features such as dose reminders, inhalation technique feedback, and wireless connectivity. The smart features of these inhalers empower patients to actively engage in their asthma management by tracking medication usage and monitoring respiratory patterns. This data is then seamlessly transmitted to healthcare providers, enabling personalized treatment plans and timely interventions. The enhanced connectivity of Smart Inhalers aligns with the broader trends in digital health and telemedicine, facilitating remote patient monitoring and improving overall healthcare outcomes. As the demand for more efficient and patient-centric healthcare solutions grows, the market for Smart Inhalers is expected to expand significantly. The convergence of respiratory care with smart technology not only addresses the evolving needs of asthma patients but also positions the Global Asthma Monitoring Device Market at the forefront of innovation in chronic disease management.

End-User Insights

Based on End-User, the Hospitals & Clinics emerged as the dominating segment in the global market for Asthma Monitoring Device in 2024. Hospitals and clinics are poised to be key drivers of growth in the Global Asthma Monitoring Device Market. As healthcare institutions increasingly prioritize comprehensive and patient-centric care, the integration of asthma monitoring devices becomes imperative for optimizing respiratory health management. Hospitals and clinics, acting as pivotal points in the healthcare delivery system, are instrumental in shaping the adoption and utilization of these devices. The demand for asthma monitoring devices is expected to surge in healthcare settings, driven by the need for more efficient and proactive approaches to respiratory care. These devices offer healthcare providers valuable real-time data, facilitating informed decision-making and personalized treatment plans. The integration of asthma monitoring devices aligns with the broader trend of digital transformation in healthcare, enhancing the quality of patient care and streamlining clinical workflows. Moreover, the rising prevalence of asthma and the emphasis on preventive healthcare further underscore the significance of monitoring devices in hospitals and clinics. As these institutions prioritize the implementation of advanced technologies to improve patient outcomes, the Global Asthma Monitoring Device Market stands to benefit significantly from increased adoption within the healthcare sector.

Regional Insights

Based on Region, North America emerged as the dominant region in the Global Asthma Monitoring Device Market in 2024. The North America region is poised to be a major catalyst for driving the growth of the Global Asthma Monitoring Device Market. Several factors contribute to this, including a robust healthcare infrastructure, a high prevalence of asthma cases, and a strong emphasis on technological innovation in healthcare. In North America, particularly in the United States and Canada, there is a heightened awareness of respiratory health, and a growing number of individuals are seeking advanced solutions for asthma management. The region's well-established healthcare ecosystem, characterized by a network of hospitals, clinics, and research institutions, facilitates the integration and adoption of asthma monitoring devices. Furthermore, the region's affinity for cutting-edge healthcare technologies, coupled with a favorable regulatory environment, encourages the development and deployment of innovative asthma monitoring solutions. The presence of key market players and research and development activities in North America further propels market growth. As healthcare stakeholders increasingly prioritize preventive care and patient engagement, the demand for asthma monitoring devices is expected to escalate in North America. The region's influential role in shaping healthcare trends positions it as a driving force behind the expansion of the Global Asthma Monitoring Device Market.

Key Market Players

  • COSMED srl.
  • Teleflex Incorporated.
  • SCHILLER.
  • Hill-Rom, Inc.
  • Koninklijke Philips N.V.
  • ICU Medical, Inc.
  • SDI Diagnostics
  • AstraZeneca plc.
  • Merck & Co., Inc.

Report Scope:

In this report, the Global Asthma Monitoring Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Asthma Monitoring Device Market, By Product:

  • Spirometer
  • Smart Inhalers
  • Peak Flow Meter

Asthma Monitoring Device Market, By End-User:

  • Hospitals & Clinics
  • Homecare
  • Diagnostic Laboratories

Asthma Monitoring Device Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Asthma Monitoring Device Market.

Available Customizations:

Global Asthma Monitoring Device market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Asthma Monitoring Device Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 5.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
  • 5.3.1 By Device
  • 5.3.2 By End-User
  • 5.3.3 By Region

6. North America Asthma Monitoring Device Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 6.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Asthma Monitoring Device Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Asthma Monitoring Device Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Asthma Monitoring Device Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device
        • 6.3.3.2.2. By End-User

7. Europe Asthma Monitoring Device Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 7.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Asthma Monitoring Device Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device
        • 7.3.1.2.2. By End-User
    • 7.3.2. Germany Asthma Monitoring Device Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Asthma Monitoring Device Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Asthma Monitoring Device Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Asthma Monitoring Device Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device
        • 7.3.5.2.2. By End-User

8. Asia Pacific Asthma Monitoring Device Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 8.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Asthma Monitoring Device Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Asthma Monitoring Device Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Asthma Monitoring Device Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Asthma Monitoring Device Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Asthma Monitoring Device Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device
        • 8.3.5.2.2. By End-User

9. South America Asthma Monitoring Device Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 9.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Asthma Monitoring Device Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device
        • 9.3.1.2.2. By End-User
    • 9.3.2. Argentina Asthma Monitoring Device Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device
        • 9.3.2.2.2. By End-User
    • 9.3.3. Colombia Asthma Monitoring Device Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device
        • 9.3.3.2.2. By End-User

10. Middle East and Africa Asthma Monitoring Device Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 10.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Asthma Monitoring Device Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device
        • 10.3.1.2.2. By End-User
    • 10.3.2. Saudi Arabia Asthma Monitoring Device Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device
        • 10.3.2.2.2. By End-User
    • 10.3.3. UAE Asthma Monitoring Device Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Asthma Monitoring Device Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. COSMED srl.
    • 15.1.1. Business Overview
    • 15.1.2. Product Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Key Personnel
    • 15.1.6. SWOT Analysis
  • 15.2. Teleflex Incorporated.
  • 15.3. SCHILLER.
  • 15.4. Hill-Rom, Inc.
  • 15.5. Koninklijke Philips N.V.
  • 15.6. ICU Medical, Inc.
  • 15.7. SDI Diagnostics
  • 15.8. AstraZeneca plc.
  • 15.9. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer